Heick A, Mosdal C, Jørgensen K, Klinken L
Department of Neurosurgery, Rigshospitalet, Copenhagen, Denmark.
Acta Neurol Scand. 1993 Mar;87(3):243-7. doi: 10.1111/j.1600-0404.1993.tb04110.x.
Cranial hyperostosis is a common secondary manifestation of intracranial meningiomas. This may occur with or without neoplastic invasion, apart or even remote from the growth. Alkaline phosphatase (AP) is one of many enzymes produced by meningiomas and is known to possess indirect ossifying properties. Meningiomatous cranial hyperostosis could possibly be mediated by a humoral mechanism. This hypothesis was tested using chemical and histochemical determination of the occurrence of the enzyme in a series of hyperostosing and non-hyperostosing meningiomas. In the hyperostosing type the content of AP was in average more than three times as high as in the non-hyperostosing type. The results thus are in favour of the induction hypothesis.
颅骨骨质增生是颅内脑膜瘤常见的继发性表现。这种情况可伴有或不伴有肿瘤侵袭,与肿瘤生长部位相隔甚至距离较远。碱性磷酸酶(AP)是脑膜瘤产生的多种酶之一,已知具有间接成骨特性。脑膜瘤性颅骨骨质增生可能由体液机制介导。本研究通过化学和组织化学方法测定一系列伴有骨质增生和不伴有骨质增生的脑膜瘤中该酶的出现情况,对这一假说进行了验证。在伴有骨质增生的类型中,AP含量平均比不伴有骨质增生的类型高出三倍多。因此,结果支持诱导假说。